Pharmacokinetic/pharmacodynamic considerations for epilepsy – depression comorbidities

References

• Beghi E, Spagnoli P, Airoldi L, et al. Emotional and affective disturbances in patients with epilepsy. Epilepsy Behav. 2002;3:255–261.
   PubMed Web of Science ®Google Scholar
• Bosak M, Dudek D, Siwek M, et al. Subtypes of interictal depressive disorders according to ICD-10 in patients with epilepsy. Neurol Neurochir Pol. 2015;49:90–94.
   PubMed Web of Science ®Google Scholar
• Hitiris N, Mohanraj R, Norrie J, et al. Predictors of pharmacoresistant epilepsy. Epilepsy Res. 2007;75:192–196.
   PubMed Web of Science ®Google Scholar
• Tellez-Zenteno JF, Patten SB, Jetté N, et al. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia. 2007;48:2336–2344.
   PubMed Web of Science ®Google Scholar
• Wiegartz P, Seidenberg M, Woodard A, et al. Co-morbid psychiatric disorder in chronic epilepsy: recognition and etiology of depression. Neurology. 1999;53:3–8.
   PubMed Web of Science ®Google Scholar
• Christensen J, Vestergaard M, Mortensen PB. Epilepsy and risk of suicide: a population-based case–control study. Lancet Neurol. 2007;6:693–698.
   PubMed Web of Science ®Google Scholar
• Kanner AM, Schachter SC, Barry JJ, et al. Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence. Epilepsy Behav. 2012;24:156–168.
   PubMed Web of Science ®Google Scholar
• Kanner AM, Byrne R, Chicharro A, et al. A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy. Neurology. 2009;72:793–799.
   PubMed Web of Science ®Google Scholar
• Kanner AM. Depression in epilepsy: a complex relation with unexpected consequences. Curr Opin Neurol. 2008;21:190–194.
   PubMed Web of Science ®Google Scholar
• Alldredge BK. Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations. Neurology. 1999;53:68–75.
   PubMed Web of Science ®Google Scholar
• Grabowska-Grzyb A, Nagańska E, Lechowicz W, et al. Description of mood disorder in patients with epilepsy. Pol Merkur Lek. 2004;16:337–339.
   PubMedGoogle Scholar
• Salzberg MR, Vajda FJE. Epilepsy, depression and antidepressant drugs. J Clin Neurosci. 2001;8:209–215.
   PubMed Web of Science ®Google Scholar
• Borowicz KK, Stepień K, Czuczwar SJ. Fluoxetine enhances the anticonvulsant effects of conventional antiepileptic drugs in maximal electroshock seizures in mice. Pharmacol Rep. 2006;58:83–90.
   PubMed Web of Science ®Google Scholar
• Borowicz KK, Furmanek-Karwowska K, Sawicka K, et al. Chronically administered fluoxetine enhances the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock model. Eur J Pharmacol. 2007;567:77–82.
   PubMed Web of Science ®Google Scholar
• Borowicz KK, Furmanek-Karwowska K, Morawska M, et al. Effect of acute and chronic treatment with milnacipran potentiates the anticonvulsant activity of conventional antiepileptic drugs in the maximal electroshock-induced seizures in mice. Psychopharmacology. 2010;207:661–669.
   PubMed Web of Science ®Google Scholar
• Borowicz KK, Gołyska D, Luszczki JJ, et al. Effect of acutely and chronically administered venlafaxine on the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock model. Eur J Pharmacol. 2011;670:114–120.
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Von Moltke LL, Harmatz JS, et al. Drug interactions with newer antidepressants: role of human cytochromes P450. J Clin Psychiatry. 1998;59:19–27.
   PubMed Web of Science ®Google Scholar
• Tripathi PP, Bozzi Y. The role of dopaminergic and serotonergic systems in neurodevelopmental disorders: a focus on epilepsy and seizure susceptibility. Bioimpacts. 2015;5:97–102.
   PubMed Web of Science ®Google Scholar
• Löscher W, Czuczwar SJ. Studies on the involvement of dopamine D-1 and D-2 receptors in the anticonvulsant effect of dopamine agonists in various rodent models of epilepsy. Eur J Pharmacol. 1986;128:55–65.
   PubMed Web of Science ®Google Scholar
• Bozzi Y, Borrelli E. The role of dopamine signaling in epileptogenesis. Front Cell Neurosci. 2013;7:1–12.
   PubMed Web of Science ®Google Scholar
• Richerson GB, Buchanan GF. The serotonin axis: shared mechanisms in seizures, depression, and SUDEP. Epilepsia. 2011;52:28–38.
   PubMed Web of Science ®Google Scholar
• Bagdy G, Kecskemeti V, Riba P, et al. Serotonin and epilepsy. J Neurochem. 2007;100:857–873.
   PubMed Web of Science ®Google Scholar
• Igelström KM. Preclinical antiepileptic actions of selective serotonin reuptake inhibitors – implications for clinical trial design. Epilepsia. 2012;53:596–605.
   PubMed Web of Science ®Google Scholar
• Dailey JW, Mishra PK, Ko KH, et al. Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats. Life Sci. 1992;50:319–326.
   PubMed Web of Science ®Google Scholar
• Yan QS, Jobe PC, Dailey JW. Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Eur J Pharmacol. 1993;252:105–112.
   Web of Science ®Google Scholar
• Trabert W, Hohagen F, Winkelmann G, et al. A seizure, and electroencephalographic signs of a lowered seizure threshold, associated with fluvoxamine treatment of obsessive-compulsive disorder. Pharmacopsychiatry. 1995;28:95–97.
   PubMed Web of Science ®Google Scholar
• Clinckers R, Zgavc T, Vermoesen K, et al. Pharmacological and neurochemical characterization of the involvement of hippocampal adrenoreceptor subtypes in the modulation of acute limbic seizures. J Neurochem. 2010;115:1595–1607.
   PubMed Web of Science ®Google Scholar
• Szot P, Weinshenker D, White SS, et al. Norepinephrine-deficient mice have increased susceptibility to seizure-inducing stimuli. J Neurosci. 1999;19:10985–10992.
   PubMed Web of Science ®Google Scholar
• Hieble JP. Subclassification and nomenclature of alpha- and beta-adrenoceptors. Curr Top Med Chem. 2007;7:129–134.
   PubMed Web of Science ®Google Scholar
• Gellman RL, Kallianos JA, McNamara JO. Alpha-2 receptors mediate an endogenous noradrenergic suppression of kindling development. J Pharmacol Exp Ther. 1987;241:891–898.
   PubMed Web of Science ®Google Scholar
• Epps SA, Weinshenker D. Rhythm and blues: animal models of epilepsy and depression comorbidity. Biochem Pharmacol. 2013;85:135–146.
   PubMed Web of Science ®Google Scholar
• Jope RS, Simonato M, Lally K. Acetylcholine content in rat brain is elevated by status epilepticus induced by lithium and pilocarpine. J Neurochem. 1987;49:944–951.
   PubMed Web of Science ®Google Scholar
• Laird HE 2nd, Hadjiconstantinou M, Neff NH. Abnormalities in the central cholinergic transmitter system of the genetically epilepsy-prone rat. Life Sci. 1986;39:783–787.
   PubMed Web of Science ®Google Scholar
• Berdiev RK, van Luijtelaar G. Cholinergic stimulation of the nucleus basalis of Meynert and reticular thalamic nucleus affects spike-and-wave discharges in WAG/Rij rats. Neurosci Lett. 2009;463:249–253.
   PubMed Web of Science ®Google Scholar
• Ali A, Ahmad FJ, Pillai KK, et al. Evidence of the antiepileptic potential of amiloride with neuropharmacological benefits in rodent models of epilepsy and behavior. Epilepsy Behav. 2004;5:322–328.
   PubMed Web of Science ®Google Scholar
• Foreman MM, Hanania T, Stratton SC, et al. In vivo pharmacological effects of JZP-4, a novel anticonvulsant, in models for anticonvulsant, antimania and antidepressant activity. Pharmacol Biochem Behav. 2008;89:523–534.
   PubMed Web of Science ®Google Scholar
• Sarkisova KY, Kuznetsova GD, Kulikov MA, et al. Spike-wave discharges are necessary for the expression of behavioral depression-like symptoms. Epilepsia. 2010;51:146–160.
   PubMed Web of Science ®Google Scholar
• Verma-Ahuja S, Evans MS, Pencek TL. Evidence for decreased calcium dependent potassium conductance in hippocampal CA3 neurons of genetically epilepsy-prone rats. Epilepsy Res. 1995;22:137–144.
   PubMed Web of Science ®Google Scholar
• Gotter AL, Santarelli VP, Doran SM, et al. TASK-3 as a potential antidepressant target. Brain Res. 2011;1416:69–79.
   PubMed Web of Science ®Google Scholar
• Miladinovic T, Nashed MG, Singh G. Overview of glutamatergic dysregulation in central pathologies. Biomolecules. 2015;5:3112–3141.
   PubMed Web of Science ®Google Scholar
• Fang Y, Wang X. Ketamine for the treatment of refractory status epilepticus. Seizure. 2015;30:14–20.
   PubMed Web of Science ®Google Scholar
• Autry AE, Adachi M, Nosyreva E, et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature. 2011;475:91–95.
   PubMed Web of Science ®Google Scholar
• Sanacora G, Gueorguieva R, Epperson CN, et al. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry. 2004;61:705–713.
   PubMed Web of Science ®Google Scholar
• Russo E, Citraro R, Scicchitano F, et al. Vigabatrin has antiepileptogenic and antidepressant effects in an animal model of epilepsy and depression comorbidity. Behav Brain Res. 2011;225:373–376.
   PubMed Web of Science ®Google Scholar
• Varga V, Sik A, Freund TF, et al. GABA(B) receptors in the median raphe nucleus: distribution and role in the serotonergic control of hippocampal activity. Neuroscience. 2002;109:119–132.
   PubMed Web of Science ®Google Scholar
• Mazarati AM, Pineda E, Shin D, et al. Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta. Neurobiol Dis. 2010;37:461–467.
   PubMed Web of Science ®Google Scholar
• Sayyah M, Beheshti S, Shokrgozar MA, et al. Antiepileptogenic and anticonvulsant activity of interleukin-1 beta in amygdala-kindled rats. Exp Neurol. 2005;191:145–153.
   PubMed Web of Science ®Google Scholar
• Paradiso B, Zucchini S, Su T, et al. Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus. Epilepsia. 2011;52:572–578.
   PubMed Web of Science ®Google Scholar
• Ugale RR, Mittal N, Hirani K, et al. Essentiality of central GABAergic neuroactive steroid allopregnanolone for anticonvulsant action of fluoxetine against pentylenetetrazole-induced seizures in mice. Brain Res. 2004;1023:102–111.
   PubMed Web of Science ®Google Scholar
• Payandemehr B, Bahremand A, Rahimian R, et al. 5-HT(3) receptor mediates the dose-dependent effects of citalopram on pentylenetetrazole-induced clonic seizure in mice: involvement of nitric oxide. Epilepsy Res. 2012;101:217–227.
   PubMed Web of Science ®Google Scholar
• Hughes IE, Radwan S. The relative toxicity of amitriptyline, imipramine, maprotiline and mianserin in rabbits in vivo. Br J Pharmacol. 1979;65:331–338.
   PubMed Web of Science ®Google Scholar
• Koella WP, Glatt A, Klebs K, et al. Epileptic phenomena induced in the cat by the antidepressants maprotiline, imipramine, clomipramine, and amitriptyline. Biol Psychiatry. 1979;14:485–497.
   PubMed Web of Science ®Google Scholar
• Ago J, Ishikawa T, Matsumoto N, et al. Epileptiformic activity induced by antidepressants in amygdala-kindled rats. Eur J Pharmacol. 2007;560:23–28.
   PubMed Web of Science ®Google Scholar
• Krijzer F, Snelder M, Bradford D. Comparison of the (pro)convulsive properties of fluvoxamine and clovoxamine with eight other antidepressants in an animal model. Neuropsychobiology. 1984;12:249–254.
   PubMed Web of Science ®Google Scholar
• Freitas RM, Sousa FCF, Viana GSB, et al. Effect of gabaergic, glutamatergic, antipsychotic and antidepressant drugs on pilocarpine-induced seizures and status epilepticus. Neurosci Lett. 2006;408:79–83.
   PubMed Web of Science ®Google Scholar
• Knobloch LC, Goldstein JM, Malick JB. Effects of acute and subacute antidepressant treatment on kindled seizures in rats. Pharmacol Biochem Behav. 1982;17:461–465.
   PubMed Web of Science ®Google Scholar
• Clifford DB, Rutherford JL, Hicks FG, et al. Acute effects of antidepressants on hippocampal seizures. Ann Neurol. 1985;18:692–697.
   PubMed Web of Science ®Google Scholar
• Kleinrok Z, Gustaw J, Czuczwar SJ. Influence of antidepressant drugs on seizure susceptibility and the anticonvulsant activity of valproate in mice. J Neural Transm Suppl. 1991;34:85–90.
   PubMedGoogle Scholar
• Raju SS, Noor AR, Gurthu S, et al. Effect of fluoxetine on maximal electroshock seizures in mice: acute vs chronic administration. Pharmacol Res. 1999;39:451–454.
   PubMed Web of Science ®Google Scholar
• Leander JD. Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine, and ameltolide (LY201116). Epilepsia. 1992;33:573–576.
   PubMed Web of Science ®Google Scholar
• Amabeoku GJ. The involvement of noradrenaline, 5-hydroxytryptamine and acetylcholine in imipramine-induced seizures in mice. Experientia. 1993;49:859–864.
   PubMedGoogle Scholar
• Trimble MR, Meldrum BS, Anlezark G. Effect of nomifensine on brain amines and epilepsy in photosensitive baboons. Br J Clin Pharmacol. 1977;4:101–107.
   PubMed Web of Science ®Google Scholar
• Ago J, Ishikawa T, Matsumoto N, et al. Mechanism of imipramine-induced seizures in amygdala-kindled rats. Epilepsy Res. 2006;72:1–9.
   PubMed Web of Science ®Google Scholar
• Lange SC, Julien RM, Fowler GW. Biphasic effects of imipramine in experimental models of epilepsy. Epilepsia. 1976;17:183–195.
   PubMed Web of Science ®Google Scholar
• Macêdo DS, Santos RS, Belchior LD, et al. Effect of anxiolytic, antidepressant, and antipsychotic drugs on cocaine-induced seizures and mortality. Epilepsy Behav. 2004;5:852–856.
   PubMed Web of Science ®Google Scholar
• Ahern TH, Javors MA, Eagles DA, et al. The effects of chronic norepinephrine transporter inactivation on seizure susceptibility in mice. Neuropsychopharmacology. 2006;31:730–738.
   PubMed Web of Science ®Google Scholar
• Stach R, Lazarova MB, Kacz D. The effects of antidepressant drugs on the seizures kindled from the rabbit amygdala. Pol J Pharmacol Pharm. 1980;32:505–512.
   PubMedGoogle Scholar
• Smolders I, Clinckers R, Meurs A, et al. Direct enhancement of hippocampal dopamine or serotonin levels as a pharmacodynamic measure of combined antidepressant-anticonvulsant action. Neuropharmacology. 2008;54:1017–1028.
   PubMed Web of Science ®Google Scholar
• Peterson SL, Trzeciakowski JP, St Mary JS. Chronic but not acute treatment with antidepressants enhances the electroconvulsive seizure response in rats. Neuropharmacology. 1985;24:941–946.
   PubMed Web of Science ®Google Scholar
• Yan QS, Dailey JW, Steenbergen JL, et al. Anticonvulsant effect of enhancement of noradrenergic transmission in the superior colliculus in genetically epilepsy-prone rats (GEPRs): a microinjection study. Brain Res. 1998;780:199–209.
   PubMed Web of Science ®Google Scholar
• Borowicz KK, Piskorska B, Stępniak B, et al. Effects of fluoxetine on the anticonvulsant action of valproate and ethosuximide in mouse model of myoclonic convulsions. Ann Agric Environ Med. 2012;19:487–490.
   PubMed Web of Science ®Google Scholar
• Magyar J, Rusznák Z, Harasztosi C, et al. Differential effects of fluoxetine enantiomers in mammalian neural and cardiac tissues. Int J Mol Med. 2003;11:535–542.
   PubMed Web of Science ®Google Scholar
• Ceyhan M, Kayir H, Uzbay IT. Investigation of the effects of tianeptine and fluoxetine on pentylenetetrazole-induced seizures in rats. J Psychiatr Res. 2005;39:191–196.
   PubMed Web of Science ®Google Scholar
• Zienowicz M, Wisłowska A, Lehner M, et al. The effect of fluoxetine in a model of chemically induced seizures – behavioral and immunocytochemical study. Neurosci Lett. 2005;373:226–231.
   PubMed Web of Science ®Google Scholar
• Ferrero AJ, Cereseto M, Reinés A, et al. Chronic treatment with fluoxetine decreases seizure threshold in naïve but not in rats exposed to the learned helplessness paradigm: correlation with the hippocampal glutamate release. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:678–686.
   PubMed Web of Science ®Google Scholar
• Hernandez EJ, Williams PA, Dudek FE. Effects of fluoxetine and TFMPP on spontaneous seizures in rats with pilocarpine-induced epilepsy. Epilepsia. 2002;43:1337–1345.
   PubMed Web of Science ®Google Scholar
• Cardamone L, Salzberg MR, Koe AS, et al. Chronic antidepressant treatment accelerates kindling epileptogenesis in rats. Neurobiol Dis. 2014;63:194–200.
   PubMed Web of Science ®Google Scholar
• Dailey JW, Yan QS, Mishra PK, et al. Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats. J Pharmacol Exp Ther. 1992;260:533–540.
   PubMed Web of Science ®Google Scholar
• Uzbay IT. Serotonergic anti-depressants and ethanol withdrawal syndrome: a review. Alcohol Alcohol. 2008;43:15–24.
   PubMed Web of Science ®Google Scholar
• Ismaĭlova K, Miadzhidi MB. Study on the effect of selective serotonin reuptake inhibitor fluoxetine on seizures and inborn behavior of rats with different phenotype of the nervous system. Zh Vyssh Nerv Deiat Im I P Pavlova. 2012;62:745–752.
   PubMed Web of Science ®Google Scholar
• Yan QS, Jobe PC, Cheong JH, et al. Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Naunyn Schmiedeb Arch Pharmacol. 1994;350:149–152.
   PubMed Web of Science ®Google Scholar
• Pericić D, Lazić J, Svob Strac D. Anticonvulsant effects of acute and repeated fluoxetine treatment in unstressed and stressed mice. Brain Res. 2005;1033:90–95.
   PubMed Web of Science ®Google Scholar
• Pasini A, Tortorella A, Gale K. The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin. Brain Res. 1996;724:84–88.
   PubMed Web of Science ®Google Scholar
• Prendiville S, Gale K. Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats. Epilepsia. 1993;34:381–384.
   PubMed Web of Science ®Google Scholar
• Statnick M, Dailey J, Jobe P, et al. Neither intranigral fluoxetine nor 5,7-dihydroxytryptamine alter audiogenic seizures in genetically epilepsy-prone rats. Eur J Pharmacol. 1996;299:93–102.
   PubMed Web of Science ®Google Scholar
• Wada Y, Shiraishi J, Nakamura M, et al. Prolonged but not acute fluoxetine administration produces its inhibitory effect on hippocampal seizures in rats. Psychopharmacology. 1995;118:305–309.
   PubMed Web of Science ®Google Scholar
• Buterbaugh GG. Effect of drugs modifying central serotonergic function on the response of extensor and nonextensor rats to maximal electroshock. Life Sci. 1978;23:2393–2404.
   PubMed Web of Science ®Google Scholar
• Ohno Y, Sofue N, Imaoku T, et al. Serotonergic modulation of absence-like seizures in Groggy rats: a novel rat model of absence epilepsy. J Pharmacol Sci. 2010;114:99–105.
   PubMed Web of Science ®Google Scholar
• Richman A, Heinrichs SC. Seizure prophylaxis in an animal model of epilepsy by dietary fluoxetine supplementation. Epilepsy Res. 2007;74:19–27.
   PubMed Web of Science ®Google Scholar
• Kamal SM. Combination of valproate and paroxetine in mice exposed to picrotoxin. Int J Nanomedicine. 2012;7:2583–2589.
   PubMed Web of Science ®Google Scholar
• Sitges M, Aldana BI, Gómez CD, et al. The antidepressant sertraline prevents the behavioral and EEG changes induced in two animal models of seizures. Epilepsy Behav. 2012;25:511–516.
   PubMed Web of Science ®Google Scholar
• Rizwan AN, Ali A, Dua Y, et al. Effects of gabapentin and antidepressant drug combinations on convulsions and memory in mice. Pol J Pharmacol. 2003;55:965–971.
   PubMedGoogle Scholar
• Sağlam E, Uzbay IT, Kayir H, et al. Effects of venlafaxine on ethanol withdrawal syndrome in rats. Fundam Clin Pharmacol. 2004;18:693–698.
   PubMed Web of Science ®Google Scholar
• Santos Junior JG, Do Monte FHM, Russi M, et al. Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole convulsive rats. Braz J Med Biol Res. 2002;35:469–472.
   PubMed Web of Science ®Google Scholar
• Borowicz KK, Zarczuk R, Latalski M, et al. Reboxetine and its influence on the action of classical antiepileptic drugs in the mouse maximal electroshock model. Pharmacol Rep. 2014;66:430–435.
   PubMed Web of Science ®Google Scholar
• Popławska M, Wróblewska D, Borowicz KK. Interactions between an antidepressant reboxetine and four classic antiepileptic drugs in the mouse model of myoclonic seizures. Pharmacol Rep. 2015;67:1141–1146.
   PubMed Web of Science ®Google Scholar
• Barczyński B, Buszewicz G, Łuszczki JJ, et al. Low dose of bupropion significantly enhances the anticonvulsant activity of felbamate, lamotrigine and topiramate in mice. Eur J Pharmacol. 2011;650:550–555.
   PubMed Web of Science ®Google Scholar
• Vermoesen K, Massie A, Smolders I, et al. The antidepressants citalopram and reboxetine reduce seizure frequency in rats with chronic epilepsy. Epilepsia. 2012;53:870–878.
   PubMed Web of Science ®Google Scholar
• Vermoesen K, Serruys ASK, Loyens E, et al. Assessment of the convulsant liability of antidepressants using zebrafish and mouse seizure models. Epilepsy Behav. 2011;22:450–460.
   PubMed Web of Science ®Google Scholar
• Tutka P, Barczynski B, Wielosz M. Convulsant and anticonvulsant effects of bupropion in mice. Eur J Pharmacol. 2004;499:117–120.
   PubMed Web of Science ®Google Scholar
• Tutka P, Mróz T, Klucha K, et al. Bupropion-induced convulsions: preclinical evaluation of antiepileptic drugs. Epilepsy Res. 2005;64:13–22.
   PubMed Web of Science ®Google Scholar
• Lin KC, Wang CC, Wang SJ. Bupropion attenuates kainic acid-induced seizures and neuronal cell death in rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry. 2013;45:207–214.
   PubMed Web of Science ®Google Scholar
• Borowicz KK, Banach M, Zarczuk R, et al. Acute and chronic treatment with mianserin differentially affects the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock model. Psychopharmacology. 2007;195:167–174.
   PubMed Web of Science ®Google Scholar
• Borowicz KK, Gurdziel E, Czuczwar SJ. Trazodone reduces the anticonvulsant action of certain classical antiepileptics in the mouse maximal electroshock model. Pharmacol Rep. 2012;64:1135–1145.
   Web of Science ®Google Scholar
• Borowicz KK, Banach M, Piskorska B, et al. Effect of acute and chronic tianeptine on the action of classical antiepileptics in the mouse maximal electroshock model. Pharmacol Rep. 2013;65:379–388.
   PubMed Web of Science ®Google Scholar
• Pericić D, Strac DS, Vlainić J. Zimelidine decreases seizure susceptibility in stressed mice. J Neural Transm. 2006;113:1863–1871.
   PubMed Web of Science ®Google Scholar
• Silvestrini B, Cioli V, Burberi S, et al. Pharmacological properties of AF 1161, a new psychotropic drug. Int J Neuropharmacol. 1968;7:587–599.
   PubMedGoogle Scholar
• Uzbay TI, Kayir H, Ceyhan M. Effects of tianeptine on onset time of pentylenetetrazole-induced seizures in mice: possible role of adenosine A1 receptors. Neuropsychopharmacology. 2007;32:412–416.
   PubMed Web of Science ®Google Scholar
• Uzbay T, Kayir H, Celik T, et al. Acute and chronic tianeptine treatments attenuate ethanol withdrawal syndrome in rats. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:478–485.
   PubMed Web of Science ®Google Scholar
• Italiano D, Spina E, De Leon J. Pharmacokinetic and pharmacodynamic interactions between antiepileptics and antidepressants (Review). Exp Opin Drug Metabol Toxicol. 2014;10:1457–1489.
   PubMed Web of Science ®Google Scholar
• Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol. 2003;2:347–356.
   PubMed Web of Science ®Google Scholar
• Spina E, Trifirò G, Caraci F. Clinically significant drug interactions with newer antidepressants. CNS Drugs. 2012;26:39–67.
   PubMed Web of Science ®Google Scholar
• Majkowski J. Antiepileptic drugs in non-epileptic health conditions. In: Majkowski J, Bourgeois B, Patsalos P, et al., editors. Antiepileptic drugs. Combination therapy and interactions. Cambridge: Cambridge University Press; 2005. p. 369–391.
   Google Scholar
• Miziak B, Błaszczyk B, Chrościńska-Krawczyk M, et al. The problem of osteoporosis in epileptic patients taking antiepileptic drugs. Expert Opin Drug Saf. 2014;13:935–946.
   PubMed Web of Science ®Google Scholar
• Rosenstein DL, Nelson JC, Jacobs SC. Seizures associated with antidepressants; a review. J Clin Psychiatry. 1993;54:289–299.
   PubMed Web of Science ®Google Scholar
• Jobe PC. Common pathogenic mechanisms between depression and epilepsy: an experimental perspective. Epilepsy Behav. 2003;4(Suppl. 3):SS14–S24.
   PubMed Web of Science ®Google Scholar
• Jobe PC, Browning RA. The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant. Epilepsy Behav. 2005;7:602–619.
   PubMed Web of Science ®Google Scholar
• Wlaź P, Kasperek R, Wlaź A, et al. NMDA and AMPA receptors are involved in the antidepressant-like activity of tianeptine in the forced swim test in mice. Pharmacol Rep. 2011;63:1526–1532.
   PubMed Web of Science ®Google Scholar
• Deák F, Lasztóczi B, Pacher P, et al. Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells. Neuropharmacology. 2000;39:1029–1036.
   PubMed Web of Science ®Google Scholar
• Harden CL, Goldstein MA. Mood disorders in patients with epilepsy: epidemiology and management. CNS Drugs. 2002;16:291–302.
   PubMed Web of Science ®Google Scholar
• Favale E, Rubino V, Mainardi P, et al. Anticonvulsant effect of fluoxetine in humans. Neurology. 1995;45:1926–1927.
   PubMed Web of Science ®Google Scholar
• Mula M, Schmitz B, Sander JW. The pharmacological treatment of depression in adults with epilepsy. Expert Opin Pharmacother. 2008;9:3159–3168.
   PubMed Web of Science ®Google Scholar
• Spina E, Perucca E. Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs. Epilepsia. 2002;43(Suppl. 2):37–44.
   PubMed Web of Science ®Google Scholar
• Mula M, Sander JW. Suicide and epilepsy: do antiepileptic drugs increase the risk? Expert Opin Drug Saf. 2015;14:553–558.
   PubMed Web of Science ®Google Scholar